To determine the association of clinicopathological factors with mRNA SLC7A5/SLC3A2 co-expression in ER+/HER2− breast cancer, the Molecular Taxonomy of Breast Cancer International Consortium (METABRIC) cohort was used. This evidence concerns the gene SLC7A5 and breast carcinoma.